Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Polymorphisms, Their Serum Levels, and

Saeed Elahirad1, Daniel Elieh Ali Komi2, Amir Kiani3,4

  • 1Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Cardiovascular Toxicology
|November 3, 2021
PubMed

Insights

Matrix metalloproteinases (MMPs), specifically MMP-2 and MMP-9, are linked to coronary artery calcification (CAC). Genetic variations in MMP-2 and MMP-9 were associated with higher serum levels and activity of these enzymes in CAC patients, suggesting a role in calcification development.

Area of Science:

  • Cardiovascular Genetics
  • Biochemistry
  • Molecular Biology

Background:

  • Matrix metalloproteinases (MMPs) play a role in extracellular matrix remodeling.
  • Elevated serum levels and activity of MMP-2 and MMP-9 are implicated in cardiovascular diseases, including coronary artery calcification (CAC).
  • Specific single nucleotide polymorphisms (SNPs) in MMP genes may influence enzyme levels and activity, potentially impacting CAC risk.

Purpose of the Study:

  • To investigate the association between MMP-2 -1575G>A (rs243866) and MMP-9 -1562 C>T (rs3918242) SNPs and serum levels/activity of MMP-2 and MMP-9 in individuals with CAC.
  • To evaluate the relationship between these SNPs, enzyme levels/activity, and other biochemical parameters in CAC patients compared to healthy controls.

Main Methods:

  • A case-control study involving 155 CAC patients and 155 healthy controls from West Iran.
  • Genotyping of MMP-2 rs243866 and MMP-9 rs3918242 SNPs using PCR-RFLP.
  • Quantification of serum MMP-2 and MMP-9 levels by ELISA and activity by gelatin zymography.
  • Measurement of various serum biochemical parameters and blood pressure.

Main Results:

  • Serum levels and activity of both MMP-2 and MMP-9 were significantly higher in CAC patients compared to controls (P < 0.001).
  • Carriage of the A allele in MMP-2 rs243866 and the T allele in MMP-9 rs3918242 were associated with increased MMP-2 and MMP-9 serum levels and activity, respectively.
  • These genetic variants may act as risk factors, potentially predisposing individuals to CAC through enhanced extracellular matrix degradation.

Conclusions:

  • The study identifies a significant association between specific SNPs in MMP-2 and MMP-9 genes and higher serum levels and activity of these enzymes in individuals with CAC.
  • These findings suggest that MMP-2 rs243866 and MMP-9 rs3918242 variants may contribute to the pathogenesis of coronary artery calcification.
  • Targeting MMP pathways or considering these genetic markers could be relevant for understanding and managing CAC.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
157
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.6K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
261
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
479